Cerity Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.3M | Sell |
10,113
-4,529
| -31% | -$1.48M | 0.01% | 996 |
|
|
2025
Q1 | $3.95M | Buy |
14,642
+1,117
| +8% | +$302K | 0.01% | 818 |
|
|
2024
Q4 | $3.24M | Buy |
13,525
+506
| +4% | +$121K | 0.01% | 895 |
|
|
2024
Q3 | $3.58M | Buy |
13,019
+7,445
| +134% | +$2.05M | 0.01% | 848 |
|
|
2024
Q2 | $1.35M | Buy |
5,574
+2,382
| +75% | +$579K | ﹤0.01% | 1092 |
|
|
2024
Q1 | $477K | Buy |
+3,192
| New | +$477K | ﹤0.01% | 1622 |
|
|
2023
Q1 | – | Sell |
-1,070
| Closed | -$254K | – | 1848 |
|
|
2022
Q4 | $254K | Buy |
+1,070
| New | +$254K | ﹤0.01% | 1218 |
|